Characteristics of group A streptococcal variants treated with mitomycin C. Appearance of cell wall galactosamine and uridine diphosphate-N-acetylglucosamine-4-epimerase activity.
D000942:Antigens, Bacterial / Q000032:analysis; D001414:Bacitracin / Q000494:pharmacology; D002238:Carbohydrate Epimerases / Q000032:analysis*; D002241:Carbohydrates / Q000032:analysis; D002473:Cell Wall / Q000378:metabolism; D002701:Chloramphenicol / Q000494:pharmacology; D004269:DNA, Bacterial / Q000032:analysis; D003851:Deoxyribonucleases / Q000032:analysis; D005227:Fatty Acids / Q000032:analysis; D005285:Fermentation; D005688:Galactosamine / Q000032:analysis*; D005944:Glucosamine; D008826:Microbial Sensitivity Tests; D008937:Mitomycins / Q000494:pharmacology*; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D011233:Precipitin Tests; D013297:Streptococcus pyogenes / Q000032:analysis / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development / Q000276:immunology / Q000378:metabolism*; D013301:Streptolysins / Q000032:analysis; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014539:Uridine Diphosphate Sugars
D000942:Antigens, Bacterial; D002241:Carbohydrates; D004269:DNA, Bacterial; D005227:Fatty Acids; D008937:Mitomycins; D013301:Streptolysins; D014539:Uridine Diphosphate Sugars; D001414:Bacitracin; D002701:Chloramphenicol; D005688:Galactosamine; D003851:Deoxyribonucleases; D002238:Carbohydrate Epimerases; D013752:Tetracycline; D005944:Glucosamine; D010400:Penicillin G; D013307:Streptomycin